Navigation Links
WHO Warns Of Increased Risk Of Vector-borne Diseases In Tsunami-affected Areas

The World Health Organization (WHO) warned about increased risk of vector-borne diseases such as malaria and dengue fever across tsunami-affected areas in Southeast Asia. Nearly four weeks after the disaster struck the region on 26 December, the organization is strengthening its disease surveillance, stagnant water conditions creating conditions for mosquito vectors to multiply to sufficient levels, to potentially cause severe public health problems.

Most affected countries in the region are endemic for dengue fever and malaria except the Maldives, which has no malaria cases but does have dengue cases. With the onset of the rainy season, particularly in Indonesia and Sri Lanka, a rise in the cases can be expected at this time of the year.

Indonesia suffered a major dengue outbreak last year. This year too, many cases have been reported in Jakarta, since December and the national authorities have installed control measures for these. However, given the extent of destruction due to the tsunami, WHO and the Ministry of Health are concerned about the increased risk of Dengue in Aceh and are carefully monitoring the situation. Concerns for malaria remain high, too. Although there is no information to suggest an increase in malaria cases in Banda Aceh, the area is endemic for the disease. "At present, we are dealing with a lot of unknowns because of the violent environmental changes that have taken place here," explained Dr Jack Chow, Assistant Director-General responsible for malaria at WHO Headquarters during a visit to Banda Aceh today. "For example, we do not know whether mosquitoes - which generally mostly live and bite outdoors - will start biting indoors more frequently. We have to monitor for these situations and support the communities so they are protected from disease, and have access to treatment when they need it".

"To reduce the risk of a dengue fever or malaria cases, WHO is strengthening its support to national authorities to impleme
'"/>

Source:WHO


Page: 1 2 3 4

Related biology news :

1. FDA Warns Consumers Not to Use Home-Use Diagnostic Kits Marketed by Globus Media
2. FDA Warns About Antipsychotic Drugs and Elderly
3. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
4. Increased risk of osteoporosis associated with gene that one in five people have
5. Increased sensitivity to nerve signals keeps diabetes at bay
6. Finding Cures For Tropical Diseases: Is Open Source An Answer?
7. Aircraft Cabin Ventilation Influences The Transmission Of Diseases In-flight
8. A New Era Of Hope For Neglected Diseases
9. A New Era of Hope for the Worlds Most Neglected Diseases

Post Your Comments:
(Date:11/23/2009)... Applied mathematicians dissected the morphology ...cteristic long leaf with a saddle-like arc midsect...e simple cause of the lily,s fan-like shapeelastic...tial growthwas revealed by using an equally simple...ng, a postdoctoral student at Harvard,s School of ...
(Date:11/23/2009)... "incontrovertible evidence" that the volcanic sup... 73,000 years ago deforested much of central India... report. , The volcano ejected an estimated 800 ...ng a crater (now the world,s largest volcanic lake...de. Ash from the event has been found in India, th...
(Date:11/23/2009)...hire microbiologist Louis Tisa has received two gr... the actinorhizal plants, widespread woody plants ...nated soils. , The United States Department of ...lecular, cellular and biomedical sciences, $399,00...e bacteria Frankia and Casuarina, an actinorhizal ...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 1More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 2More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 3More Than One in Five 12 to 17 Year Olds Have Trouble Seeing in Class 53609 4VivaGel 28R 29 Demonstrates Anti HIV and Herpes Activity Following Human Administration 53604 1VivaGel 28R 29 Demonstrates Anti HIV and Herpes Activity Following Human Administration 53604 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 1Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 2Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 3Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 4Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 5Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures 13351 6
...overed dozens of potentially beneficial bioactive ... Amazon rain forest, including several so genetica... new taxonomical genera. , The analysis of 135 en...ing within the inner tissue of plants - by members...se at Yale will be published Monday in the journal...
...ll package sizes these days, presumably to help co...the Journal of Consumer Research found that peop...they are in small packages than large ones. And sm...to temptation in the first place. , Authors Rita ...ik Pieters, and Marcel Zeelenberg (both Tilburg Un...
...to access 3D images of biomacromolecules underlyin...lying on text to provide the understanding of biom...alled Proteopedia now provides a new resource by l...tructural information. The wiki web resource, firs...l Genome Biology, displays protein structures and ...
Other Biology News:Yale undergrads' Amazon trip yields a treasure trove of diversity 2Pay attention! Small packages may lead to overeating 2
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceut...(PTO)hasallowedthepatentapplicationfor,itsnano-par...logyisahighlyefficientapproachtoincorporatepeptide...oraldeliveryofdrugs,otherwiseadministeredasinjecti...pliedtomanymacromoleculardrugssuchasinsulin,interf...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCor...velopmentAuthority(OPDA)wererecentlyawarded$2milli...onBoard(CERB)inaprivate/publicpartnershiptoconstru...LincolnCounty,WA. ,, "Thisinvestmentwillsignifi...ver70greenjobstoLincolnCounty,"saidBlueMarbleEnerg...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswire...CalottoCapitalInc.,aleadingproviderofadvancedlaser...ilityclinicmarkets,todayreportedoperationalandfina...9. , ,Q32009Highlights,-Revenuewas$1.46millionco...as66.3percentcomparedwith66.1percentinQ3,2008,-Net...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/...hatRandyScott,GenomicHealth,sExecutiveChairman,wil...renceinNewYorkCityonTuesday,December1,2009at10:00a...dwebcastofthepresentation,visittheInvestorRelation....genomichealth.com .Pleaseconnecttothewebsiteatlea...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ented at the 12th World Conference on Lung Cancer ...wire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ...entifies,develops and commercializes differentiate...positive preliminary results from the first two co... nimotuzumab in combination with,radiation for the...
...0 Split Effective at Close of Business Today ... PLANTATION, Fla., Sept. 4 Viragen,International,... subsidiary,of Viragen, Inc. (OTC Bulletin Board: ... reverse stock split of its issued and outstanding...f business today, September 4, 2007. The reverse ...
... Sept. 4 American Oriental,Bioengineering, Inc. (...or of,plant-based pharmaceutical and nutraceutical...ny will attend the Credit Suisse Asian Technology,...henzhen, China as well as,the 3rd Semi-Annual Inve...,Carret & Co. on September 11, 2007 in Beijing, Ch...
Other Biology Technology:YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 2YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 3YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 4YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 5Viragen International to Reverse Split Its Common Stock 2Viragen International to Reverse Split Its Common Stock 3American Oriental Bioengineering Announces Participation in September Investor Conferences 2
BD BioCoat Collagen IV 150 mm Culture Dishes from BD Biosciences - Discovery Labware
Chicken Anti-Polymerase (RNA) II (DNA directed) polypeptide L Antibody, Unconjugated from CHEMICON
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Human Apoptosis Kit 50 tests from BD Biosciences Pharmingen
Biology Products: